Beneficio de cobertura para la vacuna contra el HPV

Humana now offers the vaccine for human papillomavirus (HPV) as a covered benefit for female members ages 9 to 26, following the recommendation of the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP).

What is HPV?
HPV is the most common sexually transmitted disease in the United States. The disease occurs in an estimated 50 percent of sexually active women at some time in their lives. The CDC estimates that 6.2 million new cases of HPV occur each year.

In the worst cases, HPV infections can progress to cervical or vaginal cancers. Standard treatments for HPV focus on screening, monitoring and/or the removal of warts, lesions or cancerous tissue.

About the vaccine
The approved vaccine – Gardasil®, produced by Merck – prevents infection of four strains of HPV. The Food and Drug Administration (FDA) has approved the vaccine for use in females ages 9 to 26 to prevent disease caused by certain HPV strains.

"Humana has carefully reviewed the latest medical literature and national recommendations," said Lou Hochheiser, M.D., Humana's medical director for clinical policy development and former chair of the department of family medicine at Brown Medical School. "We feel strongly that our members from age 9 to 26 ought to have this vaccine available to them."

The CDC specifically recommends the vaccine for girls and women ages 11 to 26. At the physician's discretion, girls can receive the vaccination as young as age 9. Ideally, the vaccine should be administered before exposure to HPV through sexual contact. Following are a few facts about the vaccine:

  • The HPV strains targeted by the vaccine are responsible for 70 percent of cervical cancers and 90 percent of genital warts.
  • The technology used to manufacturer the vaccine renders it incapable of causing an HPV infection.
  • The vaccine is administered in a series of three injections over a six-month period at a cost of $120 per dose.
  • HPV has no cure. Females who receive HPV vaccine should continue to follow medical screening recommendations.

Humana coverage specifics:

  • For fully-insured commercial health plan members, Gardasil is a medical benefit. This is not a prescription drug benefit.
  • For self-funded commercial plan members, Gardasil will be covered as a medical benefit up to the plan's age limit for child immunizations, unless otherwise directed by the employer. Members should confirm coverage with their employers.
  • For Humana's Medicare members, the Part D Prescription Drug benefit will cover Gardasil.

Volver arriba

 




Carta de Bruce Perkins
Políticas de cobertura médica para febrero, marzo y abril
Presentaciones que intentan facilitarle el trabajo
Los Webinars proporcionan un aprendizaje interactivo
Recordatorios importantes: Políticas y procesos de Humana
Humana se compromete a mejorar la calidad
La codificación apropiada de los exámenes retinales
   es necesaria para obtener datos precisos
Humana reconoce a los participantes de los Módulos
   de mejoramiento de la práctica médica
Actualizaciones en la gestión de farmacias
Apoyo para dejar de fumar para los afiliados de Medicare
Se facilita la determinación de elegibilidad para vacunas
Actualización del identificador nacional de proveedores (NPI)
Nuevas regulaciones en los derechos de apelación de altas hospitalarias
El asesoramiento telefónico de salud cosecha beneficios
Pautas para la codificación apropiada de la diabetes
Pregunte a los expertos